Shanghai Pharma Spending to Build Drug Distribution Business

Shanghai Pharmaceutical Holding plans to make a 2 billion RMB ($310 million) capital expenditure that will, among other things, solidify its drug distribution business in North China. The company will put 1 billion RMB ($155 million) of capital in its distribution subsidiary to bulk up its sales network. Another $80 million will go to establish a sales unit in North China, and it will spend 500 million RMB ($75 million) in an information technology venture. More details.... Stock Symbol: (SHA: 601607)     Share this with colleagues: